PRDM1 抗体
Quick Overview for PRDM1 抗体 (ABIN2668849)
抗原
See all PRDM1 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
纯化方法
- Protein G Chromatography
-
免疫原
- This PRDM1 / BLIMP1 antibody was raised against full-length recombinant human PRDM1 / BLIMP1 protein.
-
亚型
- IgG1
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
浓度
- 1 μg/μL
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
-
Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
-
储存条件
- -20 °C
-
储存方法
- Antibodies in solution can be stored at -20 °C for 2 years.
-
有效期
- 6 months
-
-
-
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas." in: The American journal of pathology, Vol. 173, Issue 1, pp. 242-52, (2008) (PubMed).
: "PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor." in: Blood, Vol. 111, Issue 7, pp. 3867-71, (2008) (PubMed).
: "Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma." in: Blood, Vol. 110, Issue 1, pp. 339-44, (2007) (PubMed).
: "PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma." in: Haematologica, Vol. 91, Issue 4, pp. 467-74, (2006) (PubMed).
: "[Malignant fibrous histiocytoma of soft tissues: early report of 10 cases]." in: Medicina clínica, Vol. 97, Issue 7, pp. 279, (1991) (PubMed).
: "
-
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas." in: The American journal of pathology, Vol. 173, Issue 1, pp. 242-52, (2008) (PubMed).
-
- PRDM1 (PR Domain Containing 1, with ZNF Domain (PRDM1))
-
别名
- PRDM1 / BLIMP1
-
分子量
- 77 & 95 kDa
-
基因ID
- 639
-
途径
- Regulation of Muscle Cell Differentiation
抗原
-